Aurora Cannabis (TSE:ACB – Get Rating) had its price target lowered by Jefferies Financial Group from C$4.10 to C$1.50 in a report released on Wednesday, BayStreet.CA reports.
A number of other analysts also recently issued reports on ACB. CIBC cut their target price on Aurora Cannabis from C$3.75 to C$2.50 and set a neutral rating for the company in a research note on Monday, September 19th. Cowen lifted their target price on shares of Aurora Cannabis from C$1.85 to C$2.00 in a research note on Tuesday, July 19th. ATB Capital upgraded shares of Aurora Cannabis from an underperform rating to a sector perform rating and boosted their target price for the company from C$3.00 to C$4.00 in a report on Thursday, September 22nd. Piper Sandler cut their price target on shares of Aurora Cannabis to C$4.00 and set a neutral rating for the company in a report on Wednesday, September 21st. Finally, Cowen upped their price objective on Aurora Cannabis from C$1.85 to C$2.00 in a report on Tuesday, July 19th. Nine equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company currently has an average rating of Hold and a consensus target price of C$2.53.
Aurora Cannabis Price Performance
ACB stock opened at C$1.77 on Wednesday. Aurora Cannabis has a 1 year low of C$1.52 and a 1 year high of C$10.87. The company has a debt-to-equity ratio of 40.69, a current ratio of 5.13 and a quick ratio of 3.35. The firm has a market capitalization of C$527.06 million and a PE ratio of -0.29. The business has a 50 day simple moving average of C$1.95 and a 200-day simple moving average of C$2.77.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
Recommended Stories
Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.
Recent Comments